TAM
MAIA icon

Tucker Asset Management’s MAIA Biotechnology MAIA Stock Holding History

Tucker Asset Management’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$522 Buy
+341
New +$445 ﹤0.01% 993
2025
Q1 		– Sell
-341
Closed -$675 – 662
2024
Q4 		$675 Buy
+341
New +$818 ﹤0.01% 1383

Other funds holding MAIA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $5.76B AUM 24.57% 1-Year Est. Return

Tucker Asset Management's MAIA Position: Q4 2025 in Review

Tucker Asset Management opened a new position in MAIA Biotechnology (MAIA) in Q4 2025: 341 shares worth $522. The stake represents ﹤0.01% of the portfolio and ranks #993 among its holdings. This is a return to the name: Tucker Asset Management previously reported a position in MAIA as recently as Q4 2024.

Tucker Asset Management first reported a position in MAIA in Q4 2024 and has held it in 2 quarters since. The position peaked at $675 in Q4 2024. 26 funds tracked by Wall St. Rank hold MAIA as of Q4 2025.

  • Tucker Asset Management held 341 shares of MAIA Biotechnology worth $522 as of Q4 2025.
  • MAIA Biotechnology was a new Tucker Asset Management position in Q4 2025.
  • MAIA Biotechnology made up ﹤0.01% of Tucker Asset Management's portfolio in Q4 2025, its #993 holding.
  • Tucker Asset Management first reported a position in MAIA Biotechnology in Q4 2024 and has held it in 2 quarters since.
  • Tucker Asset Management's MAIA Biotechnology position peaked at $675 in Q4 2024.
  • 26 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q4 2025.

Based on Tucker Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.